Given that GPR55 activation reduces glucose levels, stimulates insulin secretion from pancreatic β cells, promotes insulin signalling in myotubes, and contributes to manifestation of obesity and diabetes, the receptor could also impact on the metabolically imbalanced myocardium upon ischaemic injury20,21,44. This evidence concerns the gene GPR55 and obesity disorder.